Advanced search
Publication Cover
Substance Abuse Volume 43, 2022 - Issue 1
Journal homepage
152
Views
0
CrossRef citations to date
0
Altmetric
Commentary

Defining and supporting high-quality telehealth for patients with opioid use disorder: The promise and potential pitfalls of telehealth expansion

Christopher J. Franka Department of Family Medicine, University of Michigan, Ann Arbor, MI, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-9195-0869View further author information
, MD, PhDORCID Icon &
Lewei (Allison) Linb Department of Psychiatry, University of Michigan, Ann Arbor, MI, USA;c VA Center for Clinical Management Research, VA Ann Arbor Healthcare System, Ann Arbor, MI, USAORCID Iconhttps://orcid.org/0000-0003-2765-7814View further author information
, MD, MSORCID Icon
Pages 1370-1373 | Published online: 12 Oct 2022

References

  • Products – Vital Statistics Rapid Release – Provisional Drug Overdose Data. https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm. Published March 16, 2022. Accessed April 8, 2022.
  • Huskamp HA, Busch AB, Uscher-Pines L, Barnett ML, Riedel L, Mehrotra A. Treatment of opioid use disorder among commercially insured patients in the context of the COVID-19 pandemic. JAMA 2020;324(23):2440–2442.
  • Lin LA, Fortney JC, Bohnert ASB, Coughlin LN, Zhang L, Piette JD. Comparing telemedicine to in-person buprenorphine treatment in U.S. veterans with opioid use disorder. J Subst Abuse Treat. 2022;133:108492.
  • Samuels EA, Khatri UG, Snyder H, Wightman RS, Tofighi B, Krawczyk N. Buprenorphine Telehealth Treatment Initiation and Follow-Up During COVID-19. J Gen Intern Med. 2022;37(5):1331–1333.
  • Frank CJ, Lin LA. Telehealth for Opioid use disorder toolkit: guidance to support high-quality care. Provid Clin Support Syst. 2021;12:21.
  • The ASAM National Practice guideline for the treatment of opioid use disorder: 2020 focused update. J Addict Med 2020;14(2S):1–91.
  • Kelley AT, Incze MA, Baylis JD, et al. Patient-centered quality measurement for opioid use disorder: development of a taxonomy to address gaps in research and practice. Subst Abus. 2022;43(1):1286–1299.
  • Walden GHR. 6 - 115th Congress (2017–2018): SUPPORT for Patients and Communities Act. https://www.congress.gov/bill/115th-congress/house-bill/6. Published October 24, 2018. Accessed April 11, 2022.
  • How to Prescribe Controlled Substances to Patients.pdf. https://www.deadiversion.usdoj.gov/GDP/(DEA-DC-023)(DEA075)Decision_Tree_(Final)_33120_2007.pdf. Accessed April 15, 2022.
  • Andraka-Christou B, Bouskill K, Haffajee RL, et al. Common themes in early state policy responses to substance use disorder treatment during COVID-19. Am J Drug Alcohol Abuse. 2021;47(4):486–496.
  • Wakeman SE, Larochelle MR, Ameli O, et al. Comparative effectiveness of different treatment pathways for opioid use disorder. JAMA Netw Open. 2020;3(2):e1920622-e1920622.
  • Jarvis BP, Holtyn AF, Subramaniam S, et al. Extended-release injectable naltrexone for opioid use disorder: a systematic review. Addiction. 2018;113(7):1188–1209.
  • Huhn AS, Hobelmann JG, Strickland JC, et al. Differences in availability and use of medications for opioid use disorder in residential treatment settings in the United States. JAMA Netw Open. 2020;3(2):e1920843.
  • Schmitt SK, Phibbs CS, Piette JD. The influence of distance on utilization of outpatient mental health aftercare following inpatient substance abuse treatment. Addict Behav. 2003;28(6):1183–1192.
  • Hilty DM, Ferrer DC, Parish MB, Johnston B, Callahan EJ, Yellowlees PM. The effectiveness of telemental health: A 2013 review. Telemed J E Health. 2013;19(6):444–454.
  • Anderson KE, Saloner B, Eckstein J, et al. Quality of buprenorphine care for insured adults with opioid use disorder. Med Care. 2021;59(5):393–401.
  • Vafaie N, Kober H. Association of drug cues and craving with drug use and relapse: A systematic review and meta-analysis. JAMA Psychiatry. 2022;79(7):641–650.
  • Appropriate Use of Drug Testing in Clinical Addiction Medicine | Ovid. https://oce-ovid-com.proxy.lib.umich.edu/article/01271255-201706000-00001/PDF. Accessed April 21, 2021.
  • Sohn M, Talbert JC, Huang Z, Oser C, Freeman PR. Trends in urine drug monitoring among persons receiving long-term opioids and persons with opioid use disorder in the United States. Pain Physician. 2021;24(2):E249–E256.
  • Uscher-Pines L, Sousa J, Raja P, Mehrotra A, Barnett M, Huskamp HA. Treatment of opioid use disorder during COVID-19: experiences of clinicians transitioning to telemedicine. J Subst Abuse Treat. 2020;118:108124.
  • Cicero TJ, Ellis MS, Kasper ZA. Polysubstance use: A broader understanding of substance use during the opioid crisis. Am J Public Health. 2020;110(2):244–250.
  • Varshneya NB, Thakrar AP, Hobelmann JG, Dunn KE, Huhn AS. Evidence of buprenorphine-precipitated withdrawal in persons who use fentanyl. J Addict Med. 2022;16(4):e265–e268.
  • Cohen SM, Weimer MB, Levander XA, Peckham AM, Tetrault JM, Morford KL. Low dose initiation of buprenorphine: a narrative review and practical approach. J Addict Med. 2022;16(4):399–406.
  • Bahadoor R, Alexandre JM, Fournet L, Gellé T, Serre F, Auriacombe M. Inventory and analysis of controlled trials of mobile phone applications targeting substance use disorders: a systematic review. Front Psychiatry. 2021;12:622394.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.